Abstract
Administration of a single high dose of methamphetamine (METH) causes a rapid and reversible decrease in the activity of the tryptophan hydroxylase (TPH), the rate-limiting enzyme in the synthesis of 5-hydroxytryptamine. This effect can be reversed completely by exposing the METH-impaired enzyme to a reducing environment, which suggests that the decrease in TPH activity is a reversible oxidative consequence of free radical formation. Consistent with this hypothesis, a single METH administration to male rats increased oxygen radical formation, as demonstrated by increased striatal dihydroxybenzoic acid formation after coadministration of salicylate with METH. Prevention of METH-induced hyperthermia attenuated both the increase in dihydroxybenzoic acid formation and the decrease in TPH activity observed 1 h after METH administration. These data suggest that both reactive oxygen species and hyperthermia contribute to the acute decrease in TPH activity which results from a single METH administration.
Footnotes
-
Send reprint requests to: Annette E. Fleckenstein, Ph.D., 112 Skaggs Hall, University of Utah, Salt Lake City, UT 84112.
-
↵1 This research was supported by PHS grants DA00869, DA04222 and DA05780.
- Abbreviations:
- DHBA
- dihydroxybenzoic acid
- METH
- methamphetamine
- 5HT
- 5-hydroxytryptamine
- 5HIAA
- 5-hydroxyindoleacetic acid
- 5HTP
- 5-hydroxytryptophan
- HPLC
- high-performance liquid chromatography
- MDMA
- methylenedioxymethamphetamine
- TPH
- tryptophan hydroxylase
- HEPES
- N-[2-hydroxylethyl]piperazine-N′-[2-ethanesulfonic acid]
- Received September 4, 1996.
- Accepted June 16, 1997.
- The American Society for Pharmacology and Experimental Therapeutics
JPET articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|